AXIM Biotechnologies Receives Patent For CBD Cream For Eczema

AXIM Biotechnologies Receives Patent For CBD Cream For Eczema
March 27, 2019 Erik Ysea
In News Articles

CMW Media client AXIM Biotechnologies was featured in an article on Benzinga discussing their receiving of a Notice of Allowance for a patent application that they filed for their topical eczema cream.

“Axim said it expects that its topical cream will be one of the first CBG products available on the market — and it won’t require a prescription. With this product, AXIM expects to enter an atopic dermatitis market that is valued at $5 billion.”

Read the FULL ARTICLE HERE

Comments (0)

Leave a reply

Your email address will not be published. Required fields are marked *

*